Table 2.

Procedural data

Procedural data
	Patient cohort (n = 106)	Percentage
Rhythm at start of procedure, n (%)
SR	34	32.1%
AF	63	59.4%
AFL	4	3.8%
AT	4	3.8%
Unknown	1	0.9%
Procedure time, h:min (defined as time of initial femoral venous access to end of procedure)	3:18 ± 0:48
Total fluoroscopy time, min	25.6 ± 12.5
Treatment received during initial procedure:
Re-isolation of the PVs	19	18.0%
Re-isolation and ablation of PCPs	56	52.8%
Ablation of PCPs alone	28	26.4%
CTI/MIL/unknown	3	2.8%
Number of veins reconnected:
0	31	29.2%
1	22	20.8%
2	30	28.3%
3	12	11.3%
4	11	10.4%
Reconnected vein (number of points):
Left superior pulmonary vein	33	31.1%
Left common pulmonary vein	8	7.5%
Left inferior pulmonary vein	36	34.0%
Right superior pulmonary vein	42	39.6%
Right inferior pulmonary vein	43	40.6%
Ablation time to re-isolate veins, min:sec	8:30 ± 6:48 (n = 76)
Ablation time non-PV targets, min:sec	26:12 ± 19:18 (n = 84)
Treatment to achieve terminal rhythm at initial procedure:
SR with cardioversion (DCCV or pharmacologic)	64	60.4%
SR without cardioversion	3111	29.2%
No ablation, DCCV or Pharmacologic conversion attempteda	10.4%
Rhythm at end of initial procedure:
SR	99	93.4%
AFb	6	5.7%
AFL	1	0.9%

AF, atrial fibrillation; AFL, atrial flutter; AT, atrial tachycardia; CTI, cavotricuspid isthmus; DCCV, direct current cardioversion; MIL, mitral isthmus line; PCP, pathologic conduction pattern; PV, pulmonary vein; SR, sinus rhythm.

^aOne site, n = 11 patients, as standard of practice does not cardiovert patients in AF at the end of the procedure allowing the patient to heal. Patients either self-convert or are cardioverted between 1 and 3 months after the procedure. Four of the six patients remaining in AF were from this site.

^bFour of the six patients remaining in AF at the end of the initial procedure were from this site.